"Failure to prepare is preparing to fail."
a professional/technology services organization with proprietary methods, data
and a unique perspective founded on the scientific, management and informatics
experience and expertise of its people. Our goal is to partner with
pharmaceutical, biotechnology and technology delivery companies to help them
derive maximum value from their efforts by re-defining their discovery and/or
development process within an information-intensive context. The landscape
of drug discovery has evolved dramatically over the past several years, as new
high throughput experimental technologies and their resulting data sets have
become integral to pharmaceutical drug discovery research. These new
methods have dramatically raised the potential for increasing the number of
targets for therapeutic development as well as for increasing the overall speed
of drug development.
Likewise, technology delivery
companies, both computational or instrument/reagent focused, are delivering ever
faster, higher-throughput and precise tools to facilitate these efforts.
many drug development organizations have not been able to develop internally an
information architecture to productively deal with the latest in informatics,
process analysis, decision support, knowledge management, accelerated analysis,
data mining and intranet delivery. Similarly, technology delivery companies often are unable to
position their products appropriately within this new, integration-intense
research market. discovery
biosciences is able to bring to these companies experience and insight
into the state-of-the-art of life science informatics, market requirements and
opportunities, as well as development and deployment of such an architecture.
But more importantly, discovery biosciences will assist the customer in leveraging their unique data
generation environment or technology in order to deliver maximum value for them
and/or their customers.
biosciences aims to enhance the drug discovery and development process at
customer companies by:
Our objective is to increase the effectiveness of the drug discovery and development processes, while reducing costs and time-to-market. Legacy 'silo-based' processes can be replaced by an overall approach that creates and manages a portfolio of opportunities and discovery efforts. Analogous to the management of a financial portfolio, success will be measured by the composition of the portfolio, the derivation of value and the minimization of risk and decision-making effort.
The discovery biosciences team consists of in-house informatics, instrumentation and science trained individuals with years of industrial and academic technology development and deployment experience as well as a proven track record in market analysis, product development and partnering. We maintain a broad array of external consultants that can be directed towards particular problems as the needs arise. Also, we are able to call upon our partner companies to deliver a coordinated deployment effort when needed. In other words, we can provide precisely the team your organization needs.
Copyright © Discovery Biosciences Corporation, 2007